title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Stocks That Hit 52-Week Lows On Friday,20220506T160650,https://www.benzinga.com/markets/options/22/05/27050916/52-weeks-high-and-low-article,BBIO,0.005467,Neutral,-0.00512
"Biotech Stock Roundup: BBIO Up on BMY Deal, GILD & CMRX Offer Updates",20220518T154100,https://www.zacks.com/stock/news/1926061/biotech-stock-roundup-bbio-up-on-bmy-deal-gild-cmrx-offer-updates,BBIO,0.107351,Neutral,0.026429
"Small-Cell Lung Cancer Market to Accelerate Substantially During the Study Period  ( 2019-2032 ) , Assesses DelveInsight | Leading Companies - Amgen, Novartis, AbbVie, BMS, Clovis Oncology, Cardiff Oncology, Roche, Daiichi Sankyo",20231004T210100,https://www.prnewswire.com/news-releases/small-cell-lung-cancer-market-to-accelerate-substantially-during-the-study-period-20192032-assesses-delveinsight--leading-companies----amgen-novartis-abbvie-bms-clovis-oncology-cardiff-oncology-roche-daiichi-sankyo-301946615.html,BBIO,0.043539,Neutral,-0.10057
"BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday - Archer Aviation  ( NYSE:ACHR ) , BridgeBio Pharma  ( NASDAQ:BBIO ) ",20241125T152128,https://www.benzinga.com/24/11/42166800/bridgebio-pharma-rigetti-computing-bath-body-works-and-other-big-stocks-moving-higher-on-monday,BBIO,0.269776,Bullish,0.407731
"Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate  ( ADC )  Toolkit - Akari Therapeutics  ( NASDAQ:AKTX ) , Peak Bio  ( OTC:PKBO ) ",20240305T130000,https://www.benzinga.com/pressreleases/24/03/g37479142/akari-therapeutics-and-peak-bio-announce-definitive-agreement-to-merge-as-equals-creating-an-expan,BBIO,0.012875,Neutral,0.0
"Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate  ( ADC )  Toolkit - Akari Therapeutics  ( NASDAQ:AKTX ) , Peak Bio  ( OTC:PKBO ) ",20240305T130000,https://www.benzinga.com/pressreleases/24/03/g37479163/akari-therapeutics-and-peak-bio-announce-definitive-agreement-to-merge-as-equals-creating-an-expan,BBIO,0.012869,Neutral,0.0
"The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More",20220512T124254,https://www.benzinga.com/general/biotech/22/05/27161064/the-daily-biotech-pulse-bristol-myers-bridgebio-ink-oncology-pact-fda-nod-for-lava-therapeutics-b,BBIO,0.120531,Neutral,0.004187
